| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |